Answers are grounded in this paper and cite their sources.
Triple-negative breast cancer (TNBC) is a challenging disease to treat and there is an unmet need to introduce new tools that offers comprehensive molecular imaging of tissues. Here we introduce an untargeted correlative molecular imaging approach to shed light on TNBC responders and non-responders to chemotherapy. Desorption electrospray ionization (DESI) -mass spectrometry (MS) is an ambient technique for lipidomic/metabolomic imaging. We have developed a comprehensive pipeline to correlate Raman spectroscopy and Fourier-transform infrared spectroscopy imaging with DESI-MSI. This highly complementary transformative imaging tool can enable disruptive research by providing insights in monitoring TNBC progression and identification of new therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: